Finance Watch: Aviceda, Tenvie Among Flurry Of Pre-J.P. Morgan VC Financings
Leyden Labs Raises $70m, Buys CoV Biotechnology
Private Company Edition: Biopharma firms revealed new VC funding to highlight progress ahead of the J.P. Morgan Healthcare Conference, including Aviceda’s $207.5m series C round, Tenvie’s $200m launch, a $115m series B for Aspect Biosystems and a €90m ($93.4m) series A for Orbis.
